1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. TALIS BIOMEDICAL CORP
Talis Biomedical Corp XNAS: TLIS

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Talis Biomedical Corp is on 14 Jul 2025 for the purpose of Talis Biomedical Corp First Quarter Earnings Results for 2025 See details


Insider Trading disclosures for Talis Biomedical Corp

The latest disclosure was made by Andrew A. Lukowiak in Talis Biomedical Corp where a trade of 30,575 Stock option (right to buy) done was reported to US exchanges on Aug. 1, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Andrew A. Lukowiak President, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2023 30,575 30,575 - - Stock option (right to buy)
Rebecca Markovich Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jul 2023 13,071 13,071 - - Stock option (right to buy)
Rustem F. Ismagilov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2023 95,000 95,000 - - Stock option (right to buy)
Melissa Gilliam Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2023 95,000 95,000 - - Stock option (right to buy)
Matthew L. Posard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2023 95,000 95,000 - - Stock option (right to buy)
Randal W. Scott Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2023 95,000 95,000 - - Stock option (right to buy)
Kimberly J. Popovits Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2023 95,000 95,000 - - Stock option (right to buy)
Robert Kelley Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2023 500,000 500,000 - - Stock option (right to buy)
J. Roger Moody Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2023 300,000 300,000 - - Stock option (right to buy)
Kimberly J. Popovits Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 95,000 95,000 - - Stock Option (right to buy)
Randal W. Scott Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 95,000 95,000 - - Stock Option (right to buy)
Matthew L. Posard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 95,000 95,000 - - Stock Option (right to buy)
Melissa Gilliam Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 95,000 95,000 - - Stock Option (right to buy)
Rustem F. Ismagilov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 95,000 95,000 - - Stock Option (right to buy)
J. Roger Moody Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 500,000 500,000 - - Stock Option (right to buy)
Robert Kelley Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 723,560 723,560 - - Stock Option (right to buy)
Robert Kelley Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2021 450,000 450,000 - - Stock Option (right to buy)
J. Roger Moody Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2021 130,000 579,897 - - Stock Option (right to buy)
Douglas Liu Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2021 200,000 514,685 - - Stock Option (right to buy)
Robert Kelley Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2021 130,000 427,202 - - Stock Option (right to buy)
Kimberly J. Popovits Interim CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Aug 2021 550,000 550,000 - - Stock Option (right to buy)
Ramesh Ramakrishnan Former Officer Sale of securities on an exchange or to another person at price $ 7.66 per share. 13 Aug 2021 27,502 38,619 - 7.7 210,665 Common Stock
Ramesh Ramakrishnan Former Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Aug 2021 8,741 0 - - Stock Option (right to buy)
Ramesh Ramakrishnan Former Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Aug 2021 43,614 0 - - Stock Option (right to buy)
Ramesh Ramakrishnan Former Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. 13 Aug 2021 8,741 66,121 - 1.5 13,112 Common Stock
Ramesh Ramakrishnan Former Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. 13 Aug 2021 43,614 57,380 - 1.5 65,421 Common Stock
Randal W. Scott Director Purchase of securities on an exchange or from another person at price $ 10.11 per share. 14 May 2021 11,000 20,000 - 10.1 111,210 Common stock
Randal W. Scott Director Purchase of securities on an exchange or from another person at price $ 10.16 per share. 14 May 2021 9,000 9,000 - 10.2 91,440 Common stock
Jeryl L. Hilleman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2021 35,112 35,112 - - Stock Option (right to buy)
Brian Coe Director, Chief Executive Officer 17 Feb 2021 10,630 0 - - Series F-1 Preferred Stock
J. Roger Moody Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 16.00 per share. 17 Feb 2021 1,700 1,700 - 16 27,200 Common Stock
Kimberly J. Popovits Director 17 Feb 2021 131,642 0 - - Series E-1 Preferred Stock
Kimberly J. Popovits Director 17 Feb 2021 128,655 0 - - Series F-1 Preferred Stock
Kimberly J. Popovits Director 17 Feb 2021 300,000 0 - - Series E-1 Preferred Stock
Kimberly J. Popovits Director 17 Feb 2021 31,519 0 - - Series C-1 Preferred Stock
Ramesh Ramakrishnan Sr. Vice President, R&D Purchase of securities on an exchange or from another person at price $ 16.00 per share. 17 Feb 2021 1,000 1,000 - 16 16,000 Common Stock
Karen E. Flick Chief of Staff, Sr. VP, Legal Purchase of securities on an exchange or from another person at price $ 16.00 per share. 17 Feb 2021 2,000 2,000 - 16 32,000 Common Stock
Randal W. Scott Director 17 Feb 2021 334,546 1,087,443 - - Common Stock
Kimberly J. Popovits Director 17 Feb 2021 92,057 92,057 - - Common Stock
Kimberly J. Popovits Director Purchase of securities on an exchange or from another person at price $ 16.00 per share. 17 Feb 2021 5,300 215,090 - 16 84,800 Common Stock
Kimberly J. Popovits Director 17 Feb 2021 209,790 209,790 - - Common Stock
Kimberly J. Popovits Director 17 Feb 2021 22,041 25,776 - - Common Stock
Randal W. Scott Director 17 Feb 2021 432,749 0 - - Series F-1 Preferred Stock
Randal W. Scott Director 17 Feb 2021 478,402 0 - - Series E-1 Preferred Stock
Randal W. Scott Director 17 Feb 2021 1,076,643 0 - - Series D-1 Preferred Stock
Randal W. Scott Director Purchase of securities on an exchange or from another person at price $ 16.00 per share. 17 Feb 2021 312,500 312,500 - 16 5,000,000 Common Stock
Randal W. Scott Director 17 Feb 2021 302,621 1,390,064 - - Common Stock
Kimberly J. Popovits Director 17 Feb 2021 89,968 182,025 - - Common Stock
Randal W. Scott Director 17 Feb 2021 752,897 752,897 - - Common Stock
Douglas Liu Sr. Vice President, Operations Purchase of securities on an exchange or from another person at price $ 16.00 per share. 17 Feb 2021 4,000 4,000 - 16 64,000 Common Stock
Matthew L. Posard Director Purchase of securities on an exchange or from another person at price $ 16.00 per share. 17 Feb 2021 62,500 62,500 - 16 1,000,000 Common Stock
Brian Coe Director, Chief Executive Officer 17 Feb 2021 15,082 17,637 - - Common Stock
Brian Coe Director, Chief Executive Officer 17 Feb 2021 8,416 26,053 - - Common Stock
Brian Coe Director, Chief Executive Officer 17 Feb 2021 7,433 33,486 - - Common Stock
Brian Coe Director, Chief Executive Officer 17 Feb 2021 21,568 0 - - Series C-1 Preferred Stock
Brian Coe Director, Chief Executive Officer 17 Feb 2021 12,035 0 - - Series E-1 Preferred Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters